Inactive Instrument

Stille AB Stock Nasdaq Stockholm

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq Stockholm
- SEK - Intraday chart for Stille AB
Sales 2024 * 559M 52.8M Sales 2025 * 627M 59.27M Capitalization 1.87B 177M
Net income 2024 * 75M 7.09M Net income 2025 * 104M 9.83M EV / Sales 2024 * 3.19 x
Net cash position 2024 * 85.49M 8.08M Net cash position 2025 * 208M 19.67M EV / Sales 2025 * 2.65 x
P/E ratio 2024 *
24.9 x
P/E ratio 2025 *
17.9 x
Employees -
Yield 2024 *
1.32%
Yield 2025 *
1.61%
Free-Float 53.19%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 47 23-03-19
Director of Finance/CFO 50 20-05-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 99-12-31
Director/Board Member 61 20-12-31
Chairman 52 19-12-31
More insiders
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Calendar
More about the company